September, 2012
No. 97 (9)

Review Articles

Molecular pathogenesis of Waldenström’s macroglobulinemia

Esteban Braggio, Casey Philipsborn, Anne Novak, Lucy Hodge, Stephen Ansell, Rafael Fonseca

https://doi.org/10.3324/haematol.2012.068478

Articles

Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions

J. Luis Espinoza, Akiyoshi Takami, Katsuji Yoshioka, Katsuya Nakata, Tokiharu Sato, Yoshihito Kasahara, Shinji Nakao

https://doi.org/10.3324/haematol.2011.058529

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation

Teresa Caballero-Velázquez, Luis Ignacio Sánchez-Abarca, Silvia Gutierrez-Cosio, Belén Blanco, Cristina Calderon, Carmen Herrero, Soraya Carrancio, Concepción Serrano, Consuelo del Cañizo, Jesús F. San Miguel, José A. Pérez-Simón

https://doi.org/10.3324/haematol.2011.058677

Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis

Géraldine Salmeron, Raphaël Porcher, Anne Bergeron, Marie Robin, Régis Peffault de Latour, Christèle Ferry, Vanderson Rocha, Anna Petropoulou, Aliénor Xhaard, Claire Lacroix, Annie Sulahian, Gérard Socié, Patricia Ribaud

https://doi.org/10.3324/haematol.2011.058255

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

Norbert Gattermann, Carlo Finelli, Matteo Della Porta, Pierre Fenaux, Michael Stadler, Agnes Guerci-Bresler, Mathias Schmid, Kerry Taylor, Dominique Vassilieff, Dany Habr, Andrea Marcellari, Bernard Roubert, Christian Rose

https://doi.org/10.3324/haematol.2011.048546

Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes

Akira Yoshida, Kouichi Zokumasu, Yuji Wano, Takahiro Yamauchi, Shin Imamura, Kazutaka Takagi, Shinji Kishi, Yoshimasa Urasaki, Kaoru Tohyama, Takanori Ueda

https://doi.org/10.3324/haematol.2011.055681

A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies

Kirsten Grønbæk, Carsten Müller-Tidow, Giovanni Perini, Sören Lehmann, Marianne Bach Treppendahl, Ken Mills, Christoph Plass, Brigitte Schlegelberger

https://doi.org/10.3324/haematol.2011.058305

A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms

Giulia Minnucci, Giulia Amicarelli, Silvia Salmoiraghi, Orietta Spinelli, Marie Lorena Guinea Montalvo, Ursula Giussani, Daniel Adlerstein, Alessandro Rambaldi

https://doi.org/10.3324/haematol.2011.056184

The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia

Linda Zuurbier, Emanuel F. Petricoin, Maartje J. Vuerhard, Valerie Calvert, Clarissa Kooi, Jessica G.C.A.M. Buijs-Gladdines, Willem K. Smits, Edwin Sonneveld, Anjo J.P. Veerman, Willem A. Kamps, Martin Horstmann, Rob Pieters, Jules P.P. Meijerink

https://doi.org/10.3324/haematol.2011.059030

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003–2007

Piotr Kozlowski, Maria Åström, Lucia Ahlberg, Per Bernell, Erik Hulegårdh, Hans Hägglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr, Helene Hallböök

https://doi.org/10.3324/haematol.2011.057851

The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index

Julia Slotta-Huspenina, Ina Koch, Laurence de Leval, Gisela Keller, Margit Klier, Karin Bink, Marcus Kremer, Mark Raffeld, Falko Fend, Leticia Quintanilla-Martinez

https://doi.org/10.3324/haematol.2011.055715

Errata Corrige

Letters to the Editor

A novel deletion of β-globin promoter causing high HbA2 in an Indian population

Thiyagaraj Mayuranathan, Janakiram Rayabaram, Eunice Sindhuvi Edison, Alok Srivastava, Shaji R. Velayudhan

https://doi.org/10.3324/haematol.2012.062299

Online Only Articles

Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

Katja Sockel, Martin Bornhaeuser, Eva Mischak-Weissinger, Rudolf Trenschel, Martin Wermke, Christian Unzicker, Guido Kobbe, Jürgen Finke, Ulrich Germing, Brigitte Mohr, Jochen Greiner, Dietrich Beelen, Christian Thiede, Gerhard Ehninger, Uwe Platzbecker

https://doi.org/10.3324/haematol.2012.067629

Original Articles and Brief Reports

Pontin is essential for murine hematopoietic stem cell survival

Oxana Bereshchenko, Elena Mancini, Luisa Luciani, Adriana Gambardella, Carlo Riccardi, Claus Nerlov

https://doi.org/10.3324/haematol.2011.060251

CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL

Ute Fischer, Christian Ruckert, Bernd Hubner, Olaf Eckermann, Vera Binder, Tamam Bakchoul, Friedhelm R. Schuster, Sylvia Merk, Hans-Ulrich Klein, Monika Führer, Martin Dugas, Arndt Borkhardt

https://doi.org/10.3324/haematol.2011.056705

Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome

Jean Donadieu, Odile Fenneteau, Blandine Beaupain, Sandrine Beaufils, Florence Bellanger, Nizar Mahlaoui, Anne Lambilliotte, Nathalie Aladjidi, Yves Bertrand, Valérie Mialou, Christine Perot, Gérard Michel, Fanny Fouyssac, Catherine Paillard, Virginie Gandemer, Patrick Boutard, Jacques Schmitz, Alain Morali, Thierry Leblanc, Christine Bellanné-Chantelot, the associated investigators of the French Severe Chronic Neutropenia Registry*

https://doi.org/10.3324/haematol.2011.057489

Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler’s syndrome after pharmacological enzyme replacement therapy

Muhammad Ameer Saif, Brian W. Bigger, Karen E Brookes, Jean Mercer, Karen L. Tylee, Heather J. Church, Denise K. Bonney, Simon Jones, J. Ed Wraith, Robert F. Wynn

https://doi.org/10.3324/haematol.2011.058644

Cell Therapy and Immunotherapy

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

Tarun K. Garg, Susann M. Szmania, Junaid A. Khan, Antje Hoering, Paul A. Malbrough, Amberly Moreno-Bost, Amy D. Greenway, Joshuah D. Lingo, Xin Li, Shmuel Yaccoby, Larry J. Suva, Brian Storrie, Guido Tricot, Dario Campana, John D. Shaughnessy, Bijay P. Nair, William T. Bellamy, Joshua Epstein, Bart Barlogie, Frits van Rhee

https://doi.org/10.3324/haematol.2011.056747

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response

Ulrich Jäger, Michael Fridrik, Markus Zeitlinger, Daniel Heintel, Georg Hopfinger, Sonja Burgstaller, Christine Mannhalter, Wilhelm Oberaigner, Edit Porpaczy, Cathrin Skrabs, Christine Einberger, Johannes Drach, Markus Raderer, Alexander Gaiger, Monique Putman, Richard Greil

https://doi.org/10.3324/haematol.2011.059246

Genomic analysis of high-risk smoldering multiple myeloma

Lucía López-Corral, María Victoria Mateos, Luis A. Corchete, María Eugenia Sarasquete, Javier de la Rubia, Felipe de Arriba, Juan-José Lahuerta, Ramón García-Sanz, Jesús F. San Miguel, Norma C. Gutiérrez

https://doi.org/10.3324/haematol.2011.060780

Retractions